Cost containment and ways around it - US industry bids to press home the value of medtech
This article was originally published in Clinica
Executive Summary
In one of last year's most dramatic and unforgettable moments for the US devices industry, Sean Tunis, a high-ranking Medicare administrator, riled US industry officials by choosing the very public forum of the AdvaMed annual meeting in March to question whether certain patients with heart failure should receive implantable cardioverter-defibrillators.